Yalovenko, T., Todor, I., Lukianova, N., & Chekhun, V. (2016). Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs. Experimental Oncology.
Chicago-Zitierstil (17. Ausg.)Yalovenko, T.M, I.M Todor, N.Y Lukianova, und V.F Chekhun. "Hepcidin as a Possible Marker in Determination of Malignancy Degree and Sensitivity of Breast Cancer Cells to Cytostatic Drugs." Experimental Oncology 2016.
MLA-Zitierstil (8. Ausg.)Yalovenko, T.M, et al. "Hepcidin as a Possible Marker in Determination of Malignancy Degree and Sensitivity of Breast Cancer Cells to Cytostatic Drugs." Experimental Oncology, 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.